You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tykerb

Showing 1 - 25 of 112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Triple Negative Breast Cancer Trial in Birmingham (Combination of Veliparib + Lapatinib)

Active, not recruiting
  • Metastatic Triple Negative Breast Cancer
  • Combination of Veliparib + Lapatinib
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 25, 2022

Metastatic Pancreatic Cancer Trial in Providence (Gemcitabine 1000mg/m2 30 minutes, Lapatinib 1000mg/d, Lapatinib 1500mg/d)

Terminated
Has Results
  • Metastatic Pancreatic Cancer
  • Gemcitabine 1000mg/m2 30 minutes
  • +4 more
  • Providence, Rhode Island
    Lifespan Hospitals
Jan 5, 2022

Breast Cancer Trial in Los Angeles, Albuquerque, Houston (GW572016, lapatinib)

Completed
Has Results
  • Breast Cancer
  • Los Angeles, California
  • +2 more
Sep 2, 2021

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022

Metastatic Breast Cancer Trial in Durham (dHER2 + AS15 ASCI, Lapatinib)

Completed
Has Results
  • Metastatic Breast Cancer
  • Durham, North Carolina
    Duke University Medical Center
Nov 18, 2021

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Tumors, Breast Trial in United States (lapatinib, bevacizumab)

Completed
Has Results
  • Neoplasms, Breast
  • Tucson, Arizona
  • +8 more
Sep 28, 2021

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Los Angeles (drug, biological, other)

Terminated
  • HER2-positive Breast Cancer
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 22, 2021

Brain Cancer, Pediatric Cancers Trial in United States (Bevacizumab, Lapatinib)

Completed
Has Results
  • Brain Cancer
  • Pediatric Cancers
  • Stanford, California
  • +5 more
Aug 14, 2020

HER2 Positive Breast Cancer Trial in Guangzhou (lapatinib and capecitabine or vinorelbine)

Completed
  • HER2 Positive Breast Cancer
  • lapatinib and capecitabine or vinorelbine
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 13, 2020

Non-HPV Locally Advanced Head Neck Cancer Trial in Canada, United States (IMRT, Cisplatin, )

Active, not recruiting
Has Results
  • Non-HPV Locally Advanced Head and Neck Cancer
  • IMRT
  • +3 more
  • Birmingham, Alabama
  • +15 more
Oct 29, 2021

Vestibular Schwannoma, NF2, Neurofibromatosis 2 Trial in United States (lapatinib)

Completed
Has Results
  • Vestibular Schwannoma
  • +4 more
  • Los Angeles, California
  • +6 more
Dec 22, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Metastatic Breast Cancer Trial in Chapel Hill, Durham (BMK120, Capecitabine, BYL719)

Completed
  • Metastatic Breast Cancer
  • Chapel Hill, North Carolina
  • +1 more
Aug 24, 2020

Breast Tumors Trial in United States (Trastuzumab, pertuzumab, lapatinib)

Completed
  • Breast Neoplasms
  • Birmingham, Alabama
  • +4 more
Sep 3, 2020

Pituitary Adenomas, Prolactinomas Trial in Los Angeles, Baltimore, Boston (Lapatinib)

Completed
Has Results
  • Pituitary Adenomas
  • Prolactinomas
  • Los Angeles, California
  • +2 more
Jan 13, 2020

Metastatic Colorectal Cancer Trial in Madison (lapatinib, Capecitabine)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Madison, Wisconsin
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Dec 11, 2019

Breast Cancer Trial in United States (lapatinib ditosylate, paclitaxel albumin-stabilized nanoparticle formulation)

Completed
Has Results
  • Breast Cancer
  • lapatinib ditosylate
  • paclitaxel albumin-stabilized nanoparticle formulation
  • Chicago, Illinois
  • +4 more
Feb 24, 2020

Breast Cancer, Tumor Metastasis Trial in Baltimore (Vorinostat, Lapatinib)

Terminated
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Oct 31, 2019

Breast Cancer Trial in United States (Lapatinib, Trastuzumab, Endocrine)

Completed
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +5 more
Oct 24, 2019

CNS Metastases, HER2-positive Breast Cancer, Male Breast Cancer Trial in Los Angeles (lapatinib ditosylate, everolimus,

Completed
  • Central Nervous System Metastases
  • +4 more
  • lapatinib ditosylate
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Nov 8, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (lapatinib ditosylate, laboratory

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Metastatic Breast Cancer Trial in Taipei (lapatinib plus oral vinorelbine)

Completed
  • Metastatic Breast Cancer
  • lapatinib plus oral vinorelbine
  • Taipei, Taiwan
    Department of Oncology,National Taiwan University Hospital
May 2, 2019